Depleting copper levels may reduce the production of energy that cancer cells need to travel and establish themselves in other parts of the body by a process referred to as metastasis, according to a new study by investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center.
Weill Cornell Medicine has been awarded a five-year, $7.8 million grant from the National Heart, Lung, and Blood Institute to study whether the antibiotic doxycycline may slow the progression of emphysema in people living with well-controlled HIV.
A digital humanities project cataloging the work of 19th century poets has unearthed a trove of work that sheds light on life, history and issues of the time, including the campaign to end slavery.
The Cornell chapter of the National Society of Black Engineers is celebrating Black History Month with a variety of events expected to be well attended thanks to the student organization’s recent efforts to boost membership and revitalize its programming.
Former U.S. Ambassador to Ukraine Bill Taylor will discuss the latest developments in a region he knows well, at a virtual event on Tuesday, Feb. 22 at 7 p.m.
Wegmans is set to open this Sunday at the Brooklyn Navy Yard in New York City. Edward McLaughlin, emeritus professor of food industry management, says given Wegmans’ supermarket innovation in service and products, New York City will now be able to relish in the legendary service, restaurant-quality prepared foods and wide selection of goods that are the envy of supermarket companies around the globe.
Cornell Tech’s first virtual Open Studio – an end-of-semester event in which students present the products they built to members of the tech industry – will be held online May 15.
Gender Equality in Tech (GET) Cities, led by Cornell Tech-based Break Through Tech and SecondMuse, in partnership with Melinda Gates’ Pivotal Ventures, has launched GET DC as its next city hub.
Researchers at Weill Cornell Medicine have identified a key protein that induces the program to build specialized liver blood vessels. The discovery could lead to engineered replacement hepatic tissue to treat common liver diseases.
The Partners of Citadel and Citadel Securities have made a $2 million gift to Weill Cornell Medicine to develop new approaches to protect people from COVID-19 and identify new cases of it.
